3D Bioprinting Market Insights and Trend Analysis By Technology (Bioprinting, Micro extrusion Laser-assisted Bioprinting, Inkjet 3D Bioprinting, Magnetic 3D Bioprinting), Material (Living Cells, Hydrogels, Extracellular Matrices), Application, End-user and Leading Companies, Forecast To 2023
Pune, India - August 16, 2019 /MarketersMedia/ —
Market Trends:
Global 3D Bioprinting Market size is projected to earn revenues worth USD 1,923.02 Million with expanding CAGR of 24.5% across the assessment period 2018 to 2023. 3D bioprinting leverages 3D printing technology for the formation of biomedical components using biomaterials to imitate natural tissues and organs. Rising Cases of Organ Failures Expected to Motivate Growth Trajectory of 3D Bioprinting Market
The technology has been already used for successfully performing surgeries such as spinal implants, dental procedures, the formation of 3D ears, etc. Extensive research is being conducted for the diversification of applications of 3D bioprinting. It is expected to facilitate the performance of major surgeries such as heart transplant in the nearby future. This, in turn, is likely to keep the 3D bioprinting market highly attractive over the next couple of years. Rising Investments Being Injected Poised to Catapult Growth of 3D Bioprinting Market
Increasing demand for prosthetics is poised to catapult the market on upward trajectory. In addition, a rising number of organ failures is another major factor anticipated to motivate the expansion of the 3D bioprinting market in the upcoming years. Rising healthcare expenditures is further projected to support market growth over the next few years.
Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/869
3D Bioprinting Market Competitive Dashboard:
Some of the top companies operating in the global 3D bioprinting market are Cellink AB (Sweden), Stratasys Ltd. (U.S.), Organovo Holdings Inc. (U.S.), FUJIFILM Wako Automation Corporation (U.S.), Regenovo Biotechnology Co. Ltd. (China), Nano3D Biosciences Inc. (U.S.), EnvisionTEC GmbH (Germany), Allevi (U.S.), REGENHU Ltd. (Switzerland), Aspect Biosystems Ltd. (Canada), Cyfuse Biomedical K.K. (Japan), and Poietis (France).
Investments in research & developments have been grown by leaps and bounds in the recent years. It assures intense competition in the landscape of the market for the next couple of years. Growth strategies such as mergers and acquisitions, collaborations, technological innovations, clinical trials, etc. are anticipated to be implemented by the participants of the 3D bioprinting market for gaining an edge over competitors. In addition, the developments in the healthcare sector are also poised to unleash developmental opportunities in the market to be capitalized on by the market players.
3D Bioprinting Market Segmentation:
Based on technology, the segments of the global 3D bioprinting market are microextrusion bioprinting, magnetic 3D bioprinting, inkjet 3D bioprinting, and laser-assisted bioprinting.
The segmental analysis of the 3D bioprinting market, on the basis of material, covers extracellular matrices, living cells, and hydrogels.
The major applications-wise segments studied in the assessment of 3D bioprinting market are research and clinical applications.
The end-users identified in this MRFR report are research organizations & academic institutes, and pharmaceutical & biotechnology companies.
3D Bioprinting Market Regional Analysis:
The regional assessment of the 3D bioprinting market covers a detailed analysis of the four regional segments along with an exhaustive country-level analysis. The regions included in the analysis are - Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA). Americas holds the largest share of the market and is likely to exhibit remarkable growth over the next couple of years. Although the region is likely to benefit from research & development in medical science, the rising investments by space research agencies in making 3D bioprinting available in the International Space Station is expected to enable market growth at a remarkable pace in the years to come. Asia Pacific, according to the study, is set to expand at a fast pace owing to the rapid increase of the patient population.
Latest Industry Developments:
In July 2019, SpaceX, a private U.S. aerospace company, has recently sent a mini refrigerator-sized 3D bioprinter to the International Space Station to help the astronauts with medical facilities.
In July 2019, the National Aeronautics and Space Administration (NAS), has invested USD 73 Mn for bringing 3D bioprinting to space by 2022.
Browse Full Report Details at: https://www.marketresearchfuture.com/reports/3d-bioprinting-market-869
3D Bioprinting Market Dynamics:
Drivers
Growing Demand For Organ Transplantation
Cost-Efficiency Of 3D Bioprinting
Growing Focus Of Market Players On 3D Bioprinting
Increasing Funding And Investments For Research
Restraints
SWOT Analysis
Lack Of Awareness Regarding 3D Bioprinting
Lack Of Skilled Professionals
Opportunities
Dominance Of Start-Ups
Key Challenges
PESTEL Analysis
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Address: Pune
Website: http://www.marketresearchfuture.com/reports/3d-bioprinting-market-869
Source: MarketersMedia
Release ID: 88908766
